Medtronic plc (NYSE:MDT) 2022 Wells Fargo Healthcare Conference Call September 7, 2022 11:35 AM ET Company Participants Karen Parkhill - Executive Vice President and Chief Financial Officer Gregory Hertz - Senior Director of Investor Relations Conference Call Participants Lawrence Biegelsen - Wells Fargo Securities, LLC Lawrence Biegelsen All right. Good morning. I'm Larry Biegelsen, the Medical Device analyst at Wells Fargo. And it's my pleasure to host this session with Medtronic. With us we have, Karen P ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended July 29, 2022 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File Number 001-36820 ® Medtronic plc (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State of incorporation) (I.R.S. ...

Medtronic plc (NYSE:MDT) Q1 2023 Earnings Conference Call August 23, 2022 8:00 AM ET Company Participants Ryan Weispfenning - VP and Head, IR Geoff Martha - Chairman and CEO Karen Parkhill - CFO Sean Salmon - EVP and President, Cardiovascular Portfolio Bob White - EVP and President, Medical Surgical Portfolio Brett Wall - EVP and President, Neuroscience Portfolio Que Dallara - EVP and President, Diabetes Operating Unit Conference Call Participants Robbie Marcus - JPMorgan Vijay Kumar - Evercore ISI Travis S ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ Annual report pursuant to section 13 or 15(d) of the Securities Exchange Act of 1934. For the fiscal year ended April 29, 2022. ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File No. 1-36820 ® Medtronic plc (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State or other ...

Medtronic plc (NYSE:MDT) Goldman Sachs Global Healthcare Conference Call June 14, 2022 11:00 AM ET Company Participants Geoff Martha - Chairman & Chief Executive Officer Conference Call Participants Amit Hazan - Goldman Sachs Amit Hazan Okay. All right. Well, good morning, everyone and welcome to day two of the Goldman Sachs Healthcare Conference. I am Amit Hazan, the Medical Technology Analyst at Goldman. And it's really nice to kick off day two with Geoff Martha of Medtronic and not a better way to kick i ...

Medtronic plc (NYSE:MDT) Q4 2022 Earnings Conference Call May 26, 2022 8:00 AM ET Company Participants Ryan Weispfenning - Head of IR Geoff Martha - CEO Karen Parkhill - CFO Brad Lerman - SVP, General Counsel, Corporate Secretary Bob White - EVP and President of the Medical Surgical Portfolio Sean Salmon - EVP and President of the Cardiovascular Portfolio Conference Call Participants Vijay Kumar - Evercore ISI Travis Steed - Bank of America Merrill Lynch Larry Biegelsen - Wells Fargo Shagun Singh - RBC Ca ...

Medtronic plc (NYSE:MDT) 42nd Annual Cowen Health Care Conference Call March 7, 2022 1:30 PM ET Company Participants Karen Parkhill - Executive Vice President and Chief Financial Officer Conference Call Participants Josh Jennings - Cowen & Company Josh Jennings Good afternoon. We're continuing to move down the medical devices track at the 42nd Annual Cowen Health Care Conference. I'm Josh Jennings from the Cowen medical devices team, and we are excited to have Karen Parkhill, Executive Vice President and CF ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 28, 2022 ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934. For the transition period from __________ to __________ Commission File Number 001-36820 ® Medtronic plc (Exact name of registrant as specified in its charter) Ireland 98-1183488 (State of incorporation) (I.R ...